NEW YORK, May 7 – Bruker Daltonics reported strong revenue growth for the first quarter of 2001, with revenue jumping to $21.7 million from $14 million in the comparable quarter a year ago.

The company classified 70 percent of its revenue from life science products, 8 percent from substance detection products, and 22 percent from aftermarket products.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.